oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease
Ludger Ltd., Abingdon, UK.
Ludger Ltd., Abingdon, UK.
University of Oxford, Translational Gastroenterology Unit, Oxford, UK.
Utrecht University, Division of Biomolecular Mass Spectrometry, Utrecht, The Netherlands.
Show others and affiliations
2019 (English)In: Journal of Crohn's & Colitis, ISSN 1873-9946, E-ISSN 1876-4479, Vol. 13, no Suppl. 1, p. S32-S33Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Oxford University Press, 2019. Vol. 13, no Suppl. 1, p. S32-S33
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-73335DOI: 10.1093/ecco-jcc/jjy222.045ISI: 000460544500047OAI: oai:DiVA.org:oru-73335DiVA, id: diva2:1299159
Available from: 2019-03-26 Created: 2019-03-26 Last updated: 2019-03-26Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records BETA

Halfvarson, Jonas

Search in DiVA

By author/editor
Halfvarson, Jonas
By organisation
School of Medical Sciences
In the same journal
Journal of Crohn's & Colitis
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 54 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf